| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |